Clinically, good progress can look like: Waist circumference reducing Better fasting glucose / HbA1c (especially for diabetes/prediabetes) Improved blood pressure and lipids Less snacking, fewer cravings, better satiety Better energy and sleep consistency Plateaus: why they happen and what to do A plateau is common after the initial phase because: Your body requires fewer calories at a lower weight Hunger signals can adapt over time Activity levels sometimes drop (subconsciously) when intake is lower What helps plateaus most: Strength training 24x/week Higher protein (discuss target with your clinician/dietitian) Consistent steps or low-intensity movement Fixing hidden calories (liquid calories, weekend drift) Reviewing dose tolerance and meal patterns with your clinician Plateau doesnt mean the medication stopped working. It often means the plan needs an upgrade
Moreover, liraglutide 3.0 mg (i.e., the dose level approved for weight management for this GLP-1 RA) in combination with lifestyle intervention markedly reduced the presence of visceral fat over a period of 40 weeks ( The reductions in ROS and systemic inflammation, in combination with improvements in the other cardiometabolic parameters, are also thought to mediate the substantiated but so far formally unconfirmed kidney-protective effects of GLP-1 RAs, which may also directly or indirectly carry a HF-related benefit, considering that CKD is a prominent risk factor for HF (von Scholten et al., 2022)
Transgenic expression of TIN2 unable to bind TRF1 suggested that full TIN2 recruitment to telomeres requires TRF1 46
If a dose is missed, do not double the next injection unless a healthcare professional gives that instruction
BPC-157 showed protective effects against arrhythmias in both conditions, suggesting a stabilizing influence on cardiac electrical activity independent of potassium levels
Original Medicare generally does not provide routine coverage for GLP-1 medications prescribed solely for obesity treatment
